Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pearce

Showing results (191-200 of 1,082) with videos related to

Pageof 109
Sort By:
Pain|October 1, 1998
The relationship between gender and family history of pain with current pain experience and awareness of pain in othersMaria Koutantji, Shirley A Pearce, David A Oakley
Canadian Journal of Research|March 19, 2010
Dried whole egg powder; further studies on the effect of added substancesR L HAY, M REID, J A PEARCE
Orphanet Journal of Rare Diseases|May 7, 2022
Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patientsGalliano Zanello, Chun-Hung Chan, David A Pearce, et al.
The Cochrane Database of Systematic Reviews|July 20, 2007
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksM I Aguilar, R Hart, L A Pearce
Ophthalmic Surgery, Lasers & Imaging Retina|February 16, 2016
Management of Cytomegalovirus Retinitis in HIV and Non-HIV PatientsWilliam A Pearce, Steven Yeh, Howard F Fine
Frontiers in Microbiology|October 21, 2015
Emerging spatial patterns in Antarctic prokaryotesChun-Wie Chong, David A Pearce, Peter Convey
The Journal of Biological Chemistry|October 19, 2014
The human synaptic vesicle protein, SV2A, functions as a galactose transporter in Saccharomyces cerevisiaeMarianna Madeo, Attila D Kovács, David A Pearce
The Annals of Pharmacotherapy|May 23, 2018
Effectiveness and Safety Comparison for Systemic Corticosteroid Therapy With and Without Inhaled Corticosteroids for COPD Exacerbation ManagementJordan A Pearce, Dane L Shiltz, Qian Ding
Biochemical and Biophysical Research Communications|March 5, 2003
The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1pSubrata Chattopadhyay, Paul M Roberts, David A Pearce
Neurology|December 15, 2004
Glutamic acid decarboxylase autoimmunity in Batten disease and other disordersDavid A Pearce, Mark Atkinson, Danilo A Tagle
Pageof 109

Showing results (191-200 of 1,082) with videos related to

Sort By:
Pageof 109
Pain|October 1, 1998
The relationship between gender and family history of pain with current pain experience and awareness of pain in othersMaria Koutantji, Shirley A Pearce, David A Oakley
Canadian Journal of Research|March 19, 2010
Dried whole egg powder; further studies on the effect of added substancesR L HAY, M REID, J A PEARCE
Orphanet Journal of Rare Diseases|May 7, 2022
Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patientsGalliano Zanello, Chun-Hung Chan, David A Pearce, et al.
The Cochrane Database of Systematic Reviews|July 20, 2007
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksM I Aguilar, R Hart, L A Pearce
Ophthalmic Surgery, Lasers & Imaging Retina|February 16, 2016
Management of Cytomegalovirus Retinitis in HIV and Non-HIV PatientsWilliam A Pearce, Steven Yeh, Howard F Fine
Frontiers in Microbiology|October 21, 2015
Emerging spatial patterns in Antarctic prokaryotesChun-Wie Chong, David A Pearce, Peter Convey
The Journal of Biological Chemistry|October 19, 2014
The human synaptic vesicle protein, SV2A, functions as a galactose transporter in Saccharomyces cerevisiaeMarianna Madeo, Attila D Kovács, David A Pearce
The Annals of Pharmacotherapy|May 23, 2018
Effectiveness and Safety Comparison for Systemic Corticosteroid Therapy With and Without Inhaled Corticosteroids for COPD Exacerbation ManagementJordan A Pearce, Dane L Shiltz, Qian Ding
Biochemical and Biophysical Research Communications|March 5, 2003
The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1pSubrata Chattopadhyay, Paul M Roberts, David A Pearce
Neurology|December 15, 2004
Glutamic acid decarboxylase autoimmunity in Batten disease and other disordersDavid A Pearce, Mark Atkinson, Danilo A Tagle
Pageof 109